220 related articles for article (PubMed ID: 31451647)
1. Allosteric modulation of β-cell M
Zhu L; Rossi M; Cohen A; Pham J; Zheng H; Dattaroy D; Mukaibo T; Melvin JE; Langel JL; Hattar S; Matschinsky FM; Appella DH; Doliba NM; Wess J
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18684-18690. PubMed ID: 31451647
[TBL] [Abstract][Full Text] [Related]
2. Minireview: Novel aspects of M3 muscarinic receptor signaling in pancreatic β-cells.
Nakajima K; Jain S; Ruiz de Azua I; McMillin SM; Rossi M; Wess J
Mol Endocrinol; 2013 Aug; 27(8):1208-16. PubMed ID: 23820900
[TBL] [Abstract][Full Text] [Related]
3. Beneficial metabolic effects caused by persistent activation of beta-cell M3 muscarinic acetylcholine receptors in transgenic mice.
Gautam D; Ruiz de Azua I; Li JH; Guettier JM; Heard T; Cui Y; Lu H; Jou W; Gavrilova O; Zawalich WS; Wess J
Endocrinology; 2010 Nov; 151(11):5185-94. PubMed ID: 20843999
[TBL] [Abstract][Full Text] [Related]
4. Beta-cell M
Zhu L; Rossi M; Doliba NM; Wess J
Int Immunopharmacol; 2020 Apr; 81():106267. PubMed ID: 32044662
[TBL] [Abstract][Full Text] [Related]
5. Role of the M3 muscarinic acetylcholine receptor in beta-cell function and glucose homeostasis.
Gautam D; Han SJ; Duttaroy A; Mears D; Hamdan FF; Li JH; Cui Y; Jeon J; Wess J
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():158-69. PubMed ID: 17919190
[TBL] [Abstract][Full Text] [Related]
6. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo.
Gautam D; Han SJ; Hamdan FF; Jeon J; Li B; Li JH; Cui Y; Mears D; Lu H; Deng C; Heard T; Wess J
Cell Metab; 2006 Jun; 3(6):449-61. PubMed ID: 16753580
[TBL] [Abstract][Full Text] [Related]
7. RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo.
Ruiz de Azua I; Scarselli M; Rosemond E; Gautam D; Jou W; Gavrilova O; Ebert PJ; Levitt P; Wess J
Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7999-8004. PubMed ID: 20385802
[TBL] [Abstract][Full Text] [Related]
8. Effect of hyperglycaemia on muscarinic M3 receptor expression and secretory sensitivity to cholinergic receptor activation in islets.
Hauge-Evans AC; Reers C; Kerby A; Franklin Z; Amisten S; King AJ; Hassan Z; Vilches-Flores A; Tippu Z; Persaud SJ; Jones PM
Diabetes Obes Metab; 2014 Oct; 16(10):947-56. PubMed ID: 24720683
[TBL] [Abstract][Full Text] [Related]
9. Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor.
Weston-Green K; Huang XF; Deng C
CNS Drugs; 2013 Dec; 27(12):1069-80. PubMed ID: 24114586
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice.
Duttaroy A; Zimliki CL; Gautam D; Cui Y; Mears D; Wess J
Diabetes; 2004 Jul; 53(7):1714-20. PubMed ID: 15220195
[TBL] [Abstract][Full Text] [Related]
11. CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo.
Rossi M; Ruiz de Azua I; Barella LF; Sakamoto W; Zhu L; Cui Y; Lu H; Rebholz H; Matschinsky FM; Doliba NM; Butcher AJ; Tobin AB; Wess J
Proc Natl Acad Sci U S A; 2015 Dec; 112(49):E6818-24. PubMed ID: 26598688
[TBL] [Abstract][Full Text] [Related]
12. Novel insights into the function of β-cell M3 muscarinic acetylcholine receptors: therapeutic implications.
Ruiz de Azua I; Gautam D; Guettier JM; Wess J
Trends Endocrinol Metab; 2011 Feb; 22(2):74-80. PubMed ID: 21106385
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of Muscarinic M
Okimoto R; Ino K; Ishizu K; Takamatsu H; Sakamoto K; Yuyama H; Fuji H; Someya A; Ohtake A; Ishigami T; Masuda N; Takeda M; Kajioka S; Yoshimura N
J Pharmacol Exp Ther; 2021 Oct; 379(1):64-73. PubMed ID: 34244231
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cholinergic potentiation of insulin secretion from pancreatic islets by chronic elevation of glucose and fatty acids: Protection by casein kinase 2 inhibitor.
Doliba NM; Liu Q; Li C; Chen P; Liu C; Naji A; Matschinsky FM
Mol Metab; 2017 Oct; 6(10):1240-1253. PubMed ID: 29031723
[TBL] [Abstract][Full Text] [Related]
16. Insulin oversecretion in MSG-obese rats is related to alterations in cholinergic muscarinic receptor subtypes in pancreatic islets.
Miranda RA; Agostinho AR; Trevenzoli IH; Barella LF; Franco CC; Trombini AB; Malta A; Gravena C; Torrezan R; Mathias PC; de Oliveira JC
Cell Physiol Biochem; 2014; 33(4):1075-86. PubMed ID: 24732778
[TBL] [Abstract][Full Text] [Related]
17. Critical metabolic roles of β-cell M3 muscarinic acetylcholine receptors.
Ruiz de Azua I; Gautam D; Jain S; Guettier JM; Wess J
Life Sci; 2012 Nov; 91(21-22):986-91. PubMed ID: 22525375
[TBL] [Abstract][Full Text] [Related]
18. Effects of cholinergic m-receptor agonists on insulin release in islets from obese and lean mice of different ages: the importance of bicarbonate.
Persson-Sjögren S; Lindström P
Pancreas; 2004 Nov; 29(4):e90-9. PubMed ID: 15502638
[TBL] [Abstract][Full Text] [Related]
19. Impaired muscarinic type 3 (M3) receptor/PKC and PKA pathways in islets from MSG-obese rats.
Ribeiro RA; Balbo SL; Roma LP; Camargo RL; Barella LF; Vanzela EC; de Freitas Mathias PC; Carneiro EM; Boschero AC; Bonfleur ML
Mol Biol Rep; 2013 Jul; 40(7):4521-8. PubMed ID: 23652999
[TBL] [Abstract][Full Text] [Related]
20. SPARC promotes insulin secretion through down-regulation of RGS4 protein in pancreatic β cells.
Hu L; He F; Huang M; Zhao Q; Cheng L; Said N; Zhou Z; Liu F; Dai YS
Sci Rep; 2020 Oct; 10(1):17581. PubMed ID: 33067534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
